Previous Winners of the EHA Research Fellowships

The José Carreras Foundation-EHA Young Investigator Fellowship Program provides seed funds for promising young investigators to encourage and promote quality research in hematology. The fellowship is sponsored through the EHA via unrestricted educational grands from the three European José Carreras Foundations: José Carreras International Leukemia Foundation, Fondation José Carreras pour la lutte contre la leucèmie, Genève, and Deutsche José Carreras Leukämie Stiftung e.V.

Year	Winner	Institution	Project Title
2011	I. Salaverria Frigola, Spain	University Hospital Schleswig-Holstein/ CA4, Kiel	Integrative Genomic Profiling of CLL. From high resolution platforms to the clinical practice
2010	O. Bereshchenko, Italy	University of Perugia	Targeting hematopoietic stem cells expansion in C/EBPα mutant AML
2009	T. Mercher, France	INSERM	Role of the Notch signaling pathway in normal and malignant megakaryopoiesis
2008	S. Fröhling, United States	Brigham and Woman's Hospital, Harvard Medical School	Identifying Therapeutic Targets in CDX2-Positive Acute Myeloid Leukemia by Transcriptional Profiling and Functional Genomic Approaches
2007	Lahortiga, Belgium	University of Leuven, Center for Genetics	Investigation of MYB as a target for therapy in T-cell acute lymphoblastic leukemia
2006	M. O. Bergo, Sweden	Sahlgrenska University Hospital	Preliminary characterization of a novel K-Ras-induced Leukemia
2005	Brian Huntly, United Kingdom	Cambridge Institute for Medical Research	A micro-array approach towards the detection of novel cryptic chromosomal rearrangements involving protein tyrosine kinases.
2004	Jan Cools, Belgium	University Hospital Gasthuisberg Leuven	A micro-array approach towards the detection of novel cryptic chromosomal rearrangements involving protein tyrosine kinases.
2003	A. Benecke, France	Inserm – U417	Epigenomics of myelopoiesis and acute promyelocytic leukemia.
2002	E. van den Akker, The Netherlands	Erasmus University Medical Center Rotterdam	Dissection of the role of Evil in myeloid leukemia using conditional in vitro and in vivo models.
2001	L. Di Croce, Italy	European Institute of Oncology	Molecular genetics of acute myeloid leukemias.
2000	Ingo Tamm, Germany	Humboldt University Berlin	Prognostic Significance of Apoptosis-Regulating Proteins in Leukemia.

EHA Research Fellowships are aimed at promoting hematological research and target young basic and clinical researchers both in the field of malignant and non-malignant hematology. The Research Fellowships are fully sponsored by the European Hematology Association and designed to support salary, supplies, equipment and travel necessary for the pursuit of the recipient’s research project.

Year	Winner	Institution	Project Title
2010	Akos G. Czibere, Germany	Heinrich-Heine University	Hepigenetic control of PU.1 through long non-coding RNAs
2010	Janka Matrai, Belgium	KUL	Hepatic gene therapy for hemophilia using integration-defective lentiviral vectors: Effect of miRNA regulation on induction of immune tolerance.
2010	Florian Kuchenbauer, Germany	University of Ulm	MicroRNAs as theraputic agents in AML
2009	Martin Jädersten, Sweden	Institution of Medicine	Molecular pathology and prognosis in MDS with del(5q)
2009	Alan Ramsay, United Kingdom	Institute of Cancer (Barts and The London)	Identifying modulators of leukaemia-induced T cell suppression
2009	Cristina Scielzo, Italy	Fondazione San Raffaele del Monte Tabor	Molecular and functional characterization of HS1, a protein involved in the natural history of Chronic Lymphocytic Leukemia
2009	Steven Goossens, Belgium	VIB-Ghent University	Role of the EMT inducers Snail and SIP1 in definitive hematopoiesis and leukemia
2008	Sanne Lugthart, The Netherlands	Erasmus University Medical Center Rotterdam	EVI1, a transforming gene associated with high-risk AML: Development of diagnostic tools and application of genome-wide approaches to study mechanisms of transformation
2008	Enrico Tiacci, Germany	Institute for Cell Biology - Tumor Research	Dissection of the molecular pathogenesis of hairy cell leukemia (HCL) and splenic lymphoma with villous lymphocytes/splenic marginal zone lymphoma (SLVL/SMZL) by genome-wide integration of genetic, transcriptional and microRNA (miRNA) profiles
2008	Yehudit Birger, Israel	Sheba Medical Center	The role of the ERG oncogene in acute megakaryocytic leukemias
2008	Eva Martinez Garcia, United States	Northwestern University Feinberg School of Medicine	Epigenetic Deregulation by The Multiple Myeloma SET Domain Protein
2007	M. Milyavsky, Canada	University Health Network	A genome scale RNAi screen for genes that control the developmental program of hematopoietic stem cells
2007	G. Roué, Spain	Clinic Hospital of Barcelona, Fundació Clínic	Identification of new therapeutical targets to improve velcade tm activity in mantle cell lymphoma
2007	U. Keller, Germany	Klinikum rechts der Isar Technical University Munich	Role of the Myc-SCFSkp2/Cks1-p27Kip1 pathway in poor prognosis diffuse large B cell lymphoma
2006	M. Heuser, Canada	Terry Fox Laboratory	Molecular mechanism underlying MN1-induced leukemogenesis
2006	M. P. Bernimoulin, United States	CBR Institute for Biomedical Research	Biology of Microparticle Generation
2006	L. H. Meyer, Germany	Universitatsklinikum Ulm - Kinder und Jugendmedizin	Apoptosis and the importance for Leukogenesis
2006	J. A. Perez Simon, Spain	Hospital Clinico Universitario	New Strategies for the induction of immune tolerance; After allogeneic transplantation: selective depletion of allreactive T-cells and blockade of dendritic cells maturation
2006	R. Rosenquist, Sweden	Uppsala University	Scandinavian Population-Based Molecular Characterization of Chronic Lymphocytic Leukemia
2005	Attilio Bondanza, Italy	Fondazione Centro S. Raffaele del Monte Tabor	Safe and effective immunotherapy of Leukaemia with suicide-modified lymphocytes retaining minor HLA-specific alloreactivity.
2005	François Delhommeau, France	Hôpital Hotel Dieu	Involvement of the V617F JAK2 mutation in Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis. Consequences of the mutation in human haematopoiesis.
2005	Ton Lisman, The Netherlands	UMC Utrecht	Hypofibrinolysis and the risk of a first episode of venous thrombosis.
2005	Ralf Schmidmaier, Germany	University Hospital Munich	Targeting integrin mediated survival in multiple myeloma.
2004	Meritxell Jorda, The Netherlands	Erasmus University Medical Center Rotterdam	Expression and function of alpha E-catenin, a novel CEBP? target gene, in normal hematopoiesis and leukemia.
2004	Kathleen Freson, Belgium	University of Leuven	Hematopoietic stem cell-based gene therapy for hereditary thrombocytopenia due to gata-1 deficiency.